Symptoms and Clinical Presentation of Liver Disease and Portal HTN

In Part 1 of this series, we reviewed what came BEFORE the MELD score—Child-Turcotte-Pugh classification. We additionally discussed the history behind MELD, what is included in its calculation and why...

The Model for End-stage Liver Disease (or MELD) score is used to determine patient priority for liver transplantation. But have you ever wondered why? Let us review the history and the literature to...

A review of the study on rifaximin as an adjunctive therapy in treatment of hepatic encephalopathy.

Can polyethylene glycol (PEG) be used to treat hepatic encephalopathy in hospitalized patients?

The first "7 Minutes with an Expert" post, featuring a discussion on the cardiac evaluation of patient's with liver disease with Northwestern's Dr. Lisa VanWagner.

Ever wondered why we tell people to transfuse to a goal hemoglobin greater than 7? This is the evidence corner for you! 

Our newest LFN Quick Tips infographic is on hepatopulmonary syndrome (HPS). We review important aspects in presentation, diagnosis, and management of one of the main pulmonary consequences of end...

In high risk patients that have variceal bleeding, have you ever wondered if there may be a role for therapies other than medicines and endoscopy? This evidence corner helps to answer just that...

The latest installment in the LFN Quick Tips series involves hepatic encephalopathy. How is it identified? What are common precipitants? How can it be treated (besides with lactulose!)?

Welcome to another LFN Quick Tips. Here you will learn the basics of HRS including appropriate nomenclature, considerations in management and tips on prevention. Enjoy!